4.6 Article

Variable Region Identical IgA and IgE to Cryptococcus neoformans Capsular Polysaccharide Manifest Specificity Differences

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 290, Issue 19, Pages 12090-12100

Publisher

ELSEVIER
DOI: 10.1074/jbc.M114.618975

Keywords

Antibody; Antigen; Immunoglobulin A (IgA); Immunoglobulin E (IgE); Nuclear Magnetic Resonance (NMR); Peptides; Isotype

Funding

  1. National Institutes of Health [HL059842, AI033774, AI052733, AI033142, T32-GM007288, R37-AI033142]
  2. Institutional AIDS Training Grant [T32-AI007501]
  3. Medical Scientist Training Program Training Grant [T32-GM007288]

Ask authors/readers for more resources

Background: Ig , , and constant regions can affect Ag specificity, but this is unknown for IgE. Results: IgE and IgA variable regions differ in specificity and cleavage rates compared with each other and IgG subclasses. Conclusion: Like IgG subclasses, the IgA and IgE constant regions can affect Ag binding specificities. Significance: These results extend the principle that the constant region can affect variable region specificity to IgE. In recent years several groups have shown that isotype switching from IgM to IgG to IgA can affect the affinity and specificity of antibodies sharing identical variable (V) regions. However, whether the same applies to IgE is unknown. In this study we compared the fine specificity of V region-identical IgE and IgA to Cryptococcus neoformans capsular polysaccharide and found that these differed in specificity from each other. The IgE and IgA paratopes were probed by nuclear magnetic resonance spectroscopy with N-15-labeled peptide mimetics of cryptococcal polysaccharide antigen (Ag). IgE was found to cleave the peptide at a much faster rate than V region-identical IgG subclasses and IgA, consistent with an altered paratope. Both IgE and IgA were opsonic for C. neoformans and protected against infection in mice. In summary, V-region expression in the context of the E constant (C) region results in specificity changes that are greater than observed for comparable IgG subclasses. These results raise the possibility that expression of certain V regions in the context of and E C regions affects their function and contributes to the special properties of those isotypes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Virology

A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies

Stephen D. Graham, Huy A. Tu, Benjamin D. McElvany, Nancy R. Graham, Ariadna Grinyo, Edgar Davidson, Benjamin J. Doranz, Sean A. Diehl, Aravinda M. de Silva, Alena Janda Markmann

Summary: The study characterized a strongly neutralizing antibody B11F isolated from a patient who recovered from ZIKV, revealing a new target site on the viral envelope. This is relevant for understanding how antibodies block infection and guiding the design and evaluation of candidate vaccines.

JOURNAL OF VIROLOGY (2021)

Article Microbiology

Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals

Alena J. Markmann, Natasa Giallourou, D. Ryan Bhowmik, Yixuan J. Hou, Aaron Lerner, David R. Martinez, Lakshmanane Premkumar, Heather Root, David van Duin, Sonia Napravnik, Stephen D. Graham, Quique Guerra, Rajendra Raut, Christos J. Petropoulos, Terri Wrin, Caleb Cornaby, John Schmitz, JoAnn Kuruc, Susan Weiss, Yara Park, Ralph Baric, Aravinda M. de Silva, David M. Margolis, Luther A. Bartelt

Summary: In this study, it was found that neutralizing antibody responses in COVID-19 convalescent individuals vary in magnitude but are durable. Higher neutralizing antibody titers are independently and significantly associated with male sex, as well as with increased age and symptom grade in male donors. Cardiometabolic comorbidities are also associated with higher antibody titers independently of sex.

MSPHERE (2021)

Article Public, Environmental & Occupational Health

Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection

Md S. Bhuiyan, Ben J. Brintz, Alana L. Whitcombe, Alena J. Markmann, Luther A. Bartelt, Nicole J. Moreland, Andrew S. Azman, Daniel T. Leung

Summary: This study used random forest models to analyze antibody biomarkers in serosurveillance and found that a single spike or receptor-binding domain (RBD) antibody was sufficient for classifying infection, while a combination of two antibody biomarkers performed better in estimating time-since-infection. Nucleocapsid antibodies performed worse in classification, but can be useful for estimating time-since-infection and distinguishing infection-induced from vaccine-induced responses.

EPIDEMIOLOGY AND INFECTION (2022)

Article Biochemistry & Molecular Biology

Cryptococcus neoformans capsule regrowth experiments reveal dynamics of enlargement and architecture

Maggie P. Wear, Ella Jacobs, Siqing Wang, Scott A. McConnell, Anthony Bowen, Camilla Strother, Radames J. B. Cordero, Conor J. Crawford, Arturo Casadevall

Summary: This study developed new physical and enzymatic methods for the isolation of Cryptococcus neoformans capsule polysaccharides (CPSs) and explored their architecture and synthesis. Soluble CPS preparations were obtained through sonication or Glucanex enzyme cocktail digestion, while capsule ghosts were produced through cell disruption after Glucanex digestion, suggesting an inherent organization of CPS independent of the cell wall. The noncytotoxic sonication and Glucanex digestion also allowed the observation of capsule rebuilding and the presence of reducing end glycans throughout the capsule. Analysis of CPS preparations further revealed the conservation of glucuronoxylomannan motifs in sonicated CPS only. These findings provide new insights into capsule structure and assembly.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Immunology

Encephalitis Caused by Jamestown Canyon Virus in a Liver Transplant Patient, North Carolina, USA, 2017

Emily J. Ciccone, Alena J. Markmann, Megan L. Srinivas, Kara J. Levinson, Melissa B. Miller, David van Duin, Cynthia L. Gay

Summary: This is the first documented case of JCV in North Carolina, where a liver transplant patient presented with acute symptoms including headache, aphasia, and confusion. Additionally, it is the first report of successful recovery from JCV encephalitis through treatment with intravenous immune globulin.

OPEN FORUM INFECTIOUS DISEASES (2022)

Article Immunology

Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial

Shmuel Shoham, Evan M. Bloch, Arturo Casadevall, Daniel Hanley, Bryan Lau, Kelly Gebo, Edward Cachay, Seble G. Kassaye, James H. Paxton, Jonathan Gerber, Adam C. Levine, Arash Naeim, Judith Currier, Bela Patel, Elizabeth S. Allen, Shweta Anjan, Lawrence Appel, Sheriza Baksh, Paul W. Blair, Anthony Bowen, Patrick Broderick, Christopher A. Caputo, Valerie Cluzet, Marie Elena Cordisco, Daniel Cruser, Stephan Ehrhardt, Donald Forthal, Yuriko Fukuta, Amy L. Gawad, Thomas Gniadek, Jean Hammel, Moises A. Huaman, Douglas A. Jabs, Anne Jedlicka, Nicky Karlen, Sabra Klein, Oliver Laeyendecker, Karen Lane, Nichol McBee, Barry Meisenberg, Christian Merlo, Giselle Mosnaim, Han Sol Park, Andrew Pekosz, Joann Petrini, William Rausch, David M. Shade, Janna R. Shapiro, J. Robinson Singleton, Catherine Sutcliffe, David L. Thomas, Anusha Yarava, Martin Zand, Jonathan M. Zenilman, Aaron A. R. Tobian, David J. Sullivan

Summary: This study compared the efficacy of high titer convalescent plasma with standard plasma in preventing SARS-CoV-2 infection among exposed but uninfected individuals. The results showed that high titer convalescent plasma did not prevent SARS-CoV-2 infection.

CLINICAL INFECTIOUS DISEASES (2023)

Article Microbiology

Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020

Cesar A. Lopez, Clark H. Cunningham, Sierra Pugh, Katerina Brandt, Usaphea P. Vanna, Matthew J. Delacruz, Quique Guerra, D. Ryan Bhowmik, Samuel J. Goldstein, Yixuan J. Hou, Margaret Gearhart, Christine Wiethorn, Candace Pope, Carolyn Amditis, Kathryn Pruitt, Cinthia Newberry-Dillon, John L. Schmitz, Lakshmanane Premkumar, Adaora A. Adimora, Ralph S. Baric, Michael Emch, Ross M. Boyce, Allison E. Aiello, Bailey K. Fosdick, Daniel B. Larremore, Aravinda M. de Silva, Jonathan J. Juliano, Alena J. Markmann

Summary: This study reveals the estimated prevalence of SARS-CoV-2 infection in North Carolina in 2020, as well as the exposure disparities among different ethnoracial groups. Latinx individuals have the highest odds of exposure, and nearly half of seropositive individuals have detectable neutralizing antibodies, highlighting the importance of vaccination despite prior exposure.

MSPHERE (2022)

Article Multidisciplinary Sciences

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

Qian Wang, Yicheng Guo, Sho Iketani, Manoj S. Nair, Zhiteng Li, Hiroshi Mohri, Maple Wang, Jian Yu, Anthony D. Bowen, Jennifer Y. Chang, Jayesh G. Shah, Nadia Nguyen, Zhiwei Chen, Kathrine Meyers, Michael T. Yin, Magdalena E. Sobieszczyk, Zizhang Sheng, Yaoxing Huang, Lihong Liu, David D. Ho

Summary: SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 have become dominant in the United States and South Africa, raising concerns about their ability to evade neutralizing antibodies and compromise the efficacy of COVID-19 vaccines and therapeutic monoclonals. A systematic antigenic analysis reveals that BA.2.12.1 and BA.4/5 have different levels of resistance to antibodies, with BA.2.12.1 being modestly resistant and BA.4/5 being substantially resistant. Certain mutations in the spike protein facilitate antibody escape, but compromise the spike affinity for the viral receptor. Only bebtelovimab retains full potency against both subvariants.

NATURE (2022)

Article Immunology

Reduction in Risk of Death Among Patients Admitted With COVID-19 Between the First and Second Epidemic Waves in New York City

Anthony Bowen, Jason Zucker, Yanhan Shen, Simian Huang, Qiheng Yan, Medini K. Annavajhala, Anne-Catrin Uhlemann, Louise Kuhn, Magdalena Sobieszczyk, Delivette Castor

Summary: Using clinical and demographic data from COVID-19 hospitalizations at a tertiary New York City medical center, researchers found that a reduction in in-hospital mortality during the second epidemic wave was associated with decreased strain on healthcare resources. Adjusting for the volume of COVID-19 admissions accounted for the mortality difference between waves. This research suggests the importance of evidence-based patient risks, treatment paradigms, and augmenting hospital capacity in preparing for future epidemics.

OPEN FORUM INFECTIOUS DISEASES (2022)

Article Biochemistry & Molecular Biology

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

Qian Wang, Sho Lekthan, Zhiten Li, Liyua Liu, Yichen Guo, Yiming Huang, Anthony D. Bowen, Michael Liu, Maple Wang, Jian Yu, Riccardo Valdez, Adam S. Lauring, Zizhang Sheng, Harris H. Wang, Aubree Gordon, Lihong Liu, David D. Ho

Summary: The BQ and XBB subvariants of SARS-CoV-2 Omicron, with additional spike mutations, are rapidly expanding and have altered antibody evasion properties. Neutralization of BQ.1, BQ.1.1, XBB, and XBB.1 by vaccinated individuals and infected persons' sera was significantly impaired, including those boosted with a WA1/BA.5 bivalent mRNA vaccine. The titers against BQ and XBB subvariants were much lower than observed before, indicating that these subvariants pose a serious threat to current COVID-19 vaccines and render all authorized antibodies inactive.
Letter Medicine, General & Internal

Antibody Response to Omicron BA.4-BA.5 Bivalent Booster

Qian Wang, Anthony Bowen, Riccardo Valdez, Carmen Gherasim, Aubree Gordon, Lihong Liu, David D. D. Ho

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Multidisciplinary Sciences

Evaluation of a COVID-19 convalescent plasma program at a US academic medical center

Heather B. Root, Matt Gilleskie, Chih-Huan Lu, Andrew Gilmore, Mariama Evans, Bridget G. Nelson, William Johnson, Brian Gurney, JoAnn Kuruc, Alena J. Markmann, Amir H. Barzin, David A. Wohl, William A. Fischer, Yara A. Park, Susan Weiss, Sonia Napravnik, Ralph Baric, Aravinda M. de Silva, Anne M. Lachiewicz, David van Duin, David M. Margolis, Michael E. Herce, Luther A. Bartelt

Summary: Amidst the COVID-19 pandemic, the use of COVID-19 convalescent plasma (CCP) has gained significant scientific and clinical interest. However, there is a lack of research on implementation outcomes. This study evaluates a local CCP program at a U.S. academic medical center and provides insights into the implementation process and outcomes. It was found that rapid implementation of a CCP program can be achieved through redeployment of highly trained personnel.

PLOS ONE (2022)

Letter Infectious Diseases

SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster

Qian Wang, Anthony Bowen, Anthony R. Tam, Riccardo Valdez, Emily Stoneman, Ian A. Mellis, Aubree Gordon, Lihong Liu, David Ho

LANCET INFECTIOUS DISEASES (2023)

Article Multidisciplinary Sciences

Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boost

Manoj S. Nair, Ruy M. Ribeiro, Maple Wang, Anthony D. Bowen, Lihong Liu, Yicheng Guo, Jennifer Y. Chang, Pengfei Wang, Zizhang Sheng, Magdalena E. Sobieszczyk, Alan S. Perelson, Yaoxing Huang, David D. Ho

Summary: A study examined the durability and breadth of serum-neutralizing antibody responses against different SARS-CoV-2 variants after receiving the original COVID-19 mRNA vaccine. The decay half-lives of WA1 and Delta-nAbs were found to be approximately 60 days after the second and third vaccine doses. Surprisingly, the serum antibodies neutralizing three different Omicron subvariants showed much better durability with a half-life of >= 6 months. Furthermore, booster doses of the original COVID-19 vaccine were found to broaden antibody responses against multiple sarbecoviruses, suggesting potential protection against future spillover from animal reservoirs.

ISCIENCE (2023)

Article Health Care Sciences & Services

SARS-CoV-2 Infection in Health Care Personnel and Their Household Contacts at a Tertiary Academic Medical Center: Protocol for a Longitudinal Cohort Study

Emily J. Ciccone, Paul N. Zivich, Evans K. Lodge, Deanna Zhu, Elle Law, Elyse Miller, Jasmine L. Taylor, Suemin Chung, Jason Xu, Alexander Volfovsky, Cherese Beatty, Haley Abernathy, Elise King, Haley E. Garrett, Alena J. Markmann, Meghan E. Rebuli, Subhashini Sellers, David J. Weber, Raquel Reyes, Naseem Alavian, Jonathan J. Juliano, Ross M. Boyce, Allison E. Aiello

Summary: This study aims to determine the incidence and risk factors of SARS-CoV-2 infection among healthcare personnel at a tertiary care medical center, while actively monitoring PPE use, interactions between participants, secondary cases in households, and participant mental health. Data collection is ongoing and expected to continue through September 2021, with the goal of understanding SARS-CoV-2 transmission risks in healthcare settings and the community.

JMIR RESEARCH PROTOCOLS (2021)

No Data Available